Orforglipron Tablets – 12 mg (30 ct)

$249.00
sold out

Orforglipron Research Tablets – 12 mg (30 ct)

Orforglipron Research Tablets are formulated for laboratory and investigative research settings requiring a non-injectable, orally presented GLP-related compound for structured evaluation.

Supplied in a tablet format, this product allows for consistent unit handling, simplified storage, and precise allocation within controlled research protocols. The tablet presentation eliminates the need for reconstitution and supports streamlined workflow in research environments where repeatability and convenience are essential.

This product is intended exclusively for research and development purposes and is not designed for clinical, therapeutic, diagnostic, or human consumption use.

Orforglipron Research Tablets – 12 mg (30 ct)

Orforglipron Research Tablets are formulated for laboratory and investigative research settings requiring a non-injectable, orally presented GLP-related compound for structured evaluation.

Supplied in a tablet format, this product allows for consistent unit handling, simplified storage, and precise allocation within controlled research protocols. The tablet presentation eliminates the need for reconstitution and supports streamlined workflow in research environments where repeatability and convenience are essential.

This product is intended exclusively for research and development purposes and is not designed for clinical, therapeutic, diagnostic, or human consumption use.